Maiken Keson-Brookes

Companies

• Mural Oncology plcGeneral counsel Dec 5, 2025 to now¹
• Mural Oncology plcOfficer Nov 15, 2023 to now²
• Rubius Therapeutics (United States)General counsel Nov 20, 2019 to Feb 1, 2022³
• uniQure N.V.General counsel Jan 5, 2017 to Feb 21, 2017⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Rubius Therapeutics (United States)5,343 shares⁵Feb 1, 2022
• MOMural Oncology plc0 shares⁶Dec 5, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Dec 5, 2025Returned to company 68,834 shares of Mural Oncology plc⁶
• Jul 22, 2025Sold 2,572 shares at $2.48 of Mural Oncology plc⁷
• Jul 18, 2025Sold 2,158 shares at $2.48 of Mural Oncology plc⁸
• Mar 5, 2025Sold 1,469 shares at $3.45 of Mural Oncology plc⁹
• Mar 4, 2025Sold 1,262 shares at $3.36 of Mural Oncology plc⁹
• Mar 3, 2025Granted 35,000 shares of Mural Oncology plc⁹
• Dec 23, 2024Sold 2,555 shares at $3.27 of Mural Oncology plc¹⁰
• Jul 18, 2024Sold 2,157 shares at $3.41 of Mural Oncology plc¹¹
• Mar 1, 2024Granted 16,800 shares of Mural Oncology plc¹²
• Dec 14, 2023Granted 29,207 shares of Mural Oncology plc¹³
• Feb 1, 2022Sold 2,732 shares at $6.57 of Rubius Therapeutics (United States)⁵
• Jan 29, 2022Exercised options 8,075 shares of Rubius Therapeutics (United States)⁵